Dexamethasone

Key facts

Active substance
dexamethasone
Therapeutic area
Ophthalmology
Decision number
P/68/2008
PIP number
Dexamethasone
Pharmaceutical form(s)
Intravitreal implant in an applicator
Condition(s) / indication(s)
Other retinal vascular occlusion
Route(s) of administration
Intravitreal use
Contact for public enquiries
Allergan Pharmaceuticals International Limited

E-mail: ml-eu_reg_affairs@allergan.com
Tel. +44 (0)1628 4944444

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

Topics

How useful was this page?

Add your rating